Lixisenatide Subcutaneous and Sinemet 100/10
Determining the interaction of Lixisenatide Subcutaneous and Sinemet 100/10 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lixisenatide
Brand name: Adlyxin
Synonyms: Lixisenatide
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lixisenatide Subcutaneous-Sinemet 100/25
- Lixisenatide Subcutaneous-Sinemet 25-100
- Lixisenatide Subcutaneous-Sinemet 25-250
- Lixisenatide Subcutaneous-Sinemet 250/25
- Lixisenatide Subcutaneous-Sinemet CR
- Lixisenatide Subcutaneous-Sinemet CR 100/25
- Sinemet 100/10-Lixtraxen Injection
- Sinemet 100/10-LMD
- Sinemet 100/10-LMD Injection
- Sinemet 100/10-LMX 4 Topical application
- Sinemet 100/10-LMX 5
- Sinemet 100/10-LMX 5 Topical application